Skip to main content

Harm Reduction Interventions

  • Reference work entry
  • First Online:
Textbook of Addiction Treatment: International Perspectives

Abstract

The goal of harm reduction is to reduce both the individual and societal harms of drug use through knowledge-based interventions that change risk behaviors and risk settings. Chapter 84, “Harm Reduction Policies, Settings, and Challenges” in this textbook gives an overview of harm reduction as a public health policy. This chapter describes the main harm reduction interventions implemented in many countries around the world, synthesizes evidence on their effectiveness and risks, and summarizes key lessons learned. The focus is on illegal drugs, especially opioids and central nervous system stimulants. The interventions covered are opioid substitution treatment; needle and syringe programs; supervised drug consumption facilities; drug overdose prevention; outreach, peer education, and health promotion; testing, vaccination, and treatment of drug-related infectious diseases; interventions for stimulant users; and drug-related sexual risk reduction. Key themes stressed include the following: that harm reduction does not replace the need for treatment but adds to the capacity to respond effectively to the wide range of health and social challenges raised by drug use; that the scientific evidence shows that harm reduction interventions are effective in terms of their stated goals, as long as they are implemented appropriately within their contextual settings; and that single interventions are far more effective when implemented together as part of a broader public health policy, including steps to facilitate healthier living and safer social environments.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 339.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Amato L, Davoli M, Perucci CA, Ferri M, Faggiano F, Mattick RP (2005) An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research. J Subst Abus Treat 28:321–329

    Article  Google Scholar 

  • Booth RE, Kwiatkowski CF, Chitwood DD (2000) Sex related HIV risk behaviors: differential risks among injection drug users, crack smokers, and injection drug users who smoke crack. Drug Alcohol Depend 58:219–226

    Article  CAS  PubMed  Google Scholar 

  • Caplehorn JR, Dalton MS, Haldar F, Petrenas AM, Nisbet JG (1996) Methadone maintenance and addicts’ risk of fatal heroin overdose. Subst Use Misuse 31:177–196

    Article  CAS  PubMed  Google Scholar 

  • Castells X, Casas M, Pérez-Mañá C, Roncero C, Vidal X, Capellà D (2010) Efficacy of psychostimulant drugs for cocaine dependence. Cochrane Database Syst Rev (Online) CD007380

    Google Scholar 

  • Centers for Disease Control and Prevention (CDC) (2010) The role of STD detection and treatment in HIV prevention – CDC fact sheet. CDC, Atlanta. http://www.cdc.gov/std/hiv/STDFact-STD-HIV.htm. Accessed 3 Mar 2013

  • Centers for Disease Control and Prevention (CDC) (2012a) Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the U.S. Department of Health and Human Services. MMWR 61(RR05):1–43. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6105a1.htm. Accessed 5 Mar 2013

  • Centers for Disease Control and Prevention (CDC) (2012b) Community-based opioid overdose prevention programs providing naloxone – United States, 2010. MMWR 61:101–105. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6106a1.htm. Accessed 13 Mar 2013

  • Centers for Disease Control and Prevention (CDC) (2012c) HIV infection and HIV-associated behaviors among injecting drug users – 20 cities, United States, 2009. MMWR 61(08):133–138. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6108a1.htm?s_cid=mm6108a1_w. Accessed 14 Mar 2013

  • Centers for Disease Control and Prevention (CDC) (2013) Opioids drive continued increase in drug overdose deaths. http://www.cdc.gov/media/releases/2013/p0220_drug_overdose_deaths.html. Accessed 14 Mar 2013

  • Coffin PO, Sullivan SD (2013) Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal. Ann Intern Med 158:1–9

    Article  PubMed  Google Scholar 

  • Colfax G, Shoptaw S (2005) The methamphetamine epidemic: implications for HIV prevention and treatment. Curr HIV/AIDS Rep 2:194–199

    Article  PubMed  Google Scholar 

  • Decorte T (2000) The taming of cocaine use in European and American cities. VUB University Press, Brussels

    Google Scholar 

  • Degenhardt L, Bucello C, Mathers B, Briegleb C, Ali H, Hickman M, McLaren J (2011) Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction (Abingdon, England) 106:32–51

    Article  Google Scholar 

  • de Lima MS, de Oliveira Soares BG, Reisser AAP, Farrell M (2002) Pharmacological treatment of cocaine dependence: a systematic review. Addiction (Abingdon, England) 97:931–949

    Article  Google Scholar 

  • Department of Health and Human Services (2011) Determination that a demonstration needle exchange program would be effective in reducing drug abuse and the risk of acquired immune deficiency syndrome infection among intravenous drug users. Fed Regist 76:10038

    Google Scholar 

  • Des Jarlais DC, Friedman SR, Sotheran JL, Stoneburner R (1988) The sharing of drug injection equipment and the AIDS epidemic in New York City: the first decade. NIDA Res Monogr 80:160–175

    CAS  PubMed  Google Scholar 

  • Des Jarlais DC, Perlis T, Arasteh K et al (2004) Informed altruism” and “partner restriction” in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990–2001. J Acquir Immune Defic Syndr 35:158–166

    Article  PubMed  Google Scholar 

  • Des Jarlais DC, Arasteh K, McKnight C, Hagan H, Perlman DC, Torian LV, Beatice S, Semaan S, Friedman SR (2010) HIV infection during limited versus combined HIV prevention programs for IDUs in New York City: the importance of transmission behaviors. Drug Alcohol Depend 109:154–160

    Article  PubMed Central  PubMed  Google Scholar 

  • Doe-Simkins M, Walley AY, Epstein A, Moyer P (2009) Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose. Am J Pub Health 99:788–791

    Article  Google Scholar 

  • Dolan K, Rutter S, Wodak AD (2003) Prison-based syringe exchange programmes: a review of international research and development. Addiction (Abingdon, England) 98:153–158

    Article  Google Scholar 

  • Dolan K, Shearer J, White B, Zhou J, Kaldor J, Wodak AD (2005) Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection. Addiction (Abingdon, England) 100:820–828

    Article  Google Scholar 

  • ECDC, EMCDDA (2011) Prevention and control of infectious diseases among people who inject drugs. ECDC and EMCDDA joint guidance. European Centre for Disease Prevention and Control, Stockholm

    Google Scholar 

  • EMCDDA (2010) Problem amphetamine and methamphetamine use in Europe. Selected issue. Publications Office of the European Union, Luxembourg. http://www.emcdda.europa.eu/publications/selected-issues/problem-amphetamine. Accessed 17 Mar 2013

  • EMCDDA (2012) Annual report 2012: the state of the drugs problem in Europe. Publications Office of the European Union, Luxembourg. http://www.emcdda.europa.eu/publications/annual-report/2012. Accessed 17 Mar 2013

  • Faggiano F, Vigna-Taglianti F, Versino E, Lemma P (2003) Methadone maintenance at different dosages for opioid dependence. Cochrane Database Syst Rev (Online) CD002208

    Google Scholar 

  • Fischer B, Powis J, Firestone Cruz M, Rudzinski K, Rehm J (2008) Hepatitis C virus transmission among oral crack users: viral detection on crack paraphernalia. Eur J Gastroenterol Hepatol 20:29–32

    Article  PubMed  Google Scholar 

  • Gates S, Smith LA, Foxcroft DR (2006) Auricular acupuncture for cocaine dependence. Cochrane Database Syst Rev (Online) CD005192

    Google Scholar 

  • Gowing L, Farrell M, Bornemann R, Ali R (2004) Substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev (Online) CD004145

    Google Scholar 

  • Gowing L, Farrell MF, Bornemann R, Sullivan LE, Ali R (2011) Oral substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev (Online) CD004145

    Google Scholar 

  • Grund JP, Broadhead R, Heckathorn D, Stern SL, Anthony DL (1996) Peer-driven outreach to combat HIV among IDUs: a basic design and preliminary results. In: Rhodes T, Hartnoll R (eds) AIDS, drugs and prevention: perspectives on individual and community action. Routledge, London, pp 201–215

    Google Scholar 

  • Grund J, Coffin P, Jauffret-Roustide M, Dijkstra M, de Bruin D, Blanken P (2010) The fast and furious – cocaine, amphetamines and harm reduction. In: Rhodes T, Hedrich D (eds) Harm reduction: evidence, impacts and challenges. Publications Office of the European Union, Luxembourg, pp 191–232

    Google Scholar 

  • Haasen C, Prinzleve M, Gossop M, Fischer G, Casas M (2005) Relationship between cocaine use and mental health problems in a sample of European cocaine powder or crack users. World Psychiatry: Off J World Psychiatr Assoc (WPA) 4:173–176

    Google Scholar 

  • Hagan H, McGough JP, Thiede H, Hopkins S, Duchin J, Alexander ER (2000) Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors. J Subst Abus Treat 19:247–252

    Article  CAS  Google Scholar 

  • Harm Reduction Coalition (2012) Overdose prevention and naloxone manual. http://harmreduction.org/wp-content/uploads/2012/11/od-manual-final-links.pdf. Accessed 20 Mar 2013

  • Hedrich D (2004) European report on drug consumption rooms. EMCDDA, Lisbon. http://www.emcdda.europa.eu/html.cfm/index54125EN.html. Accessed 21 Mar 2013

  • Hedrich D, Kerr T, Dubois-Arber F (2010) Drug consumption facilities in Europe and beyond. In: Rhodes T, Hedrich D (eds) Harm reduction: evidence, impacts and challenges. Publications Office of the European Union, Luxembourg, pp 305–331

    Google Scholar 

  • Hedrich D, Alves P, Farrell M, Stöver H, Møller L, Mayet S (2012) The effectiveness of opioid maintenance treatment in prison settings: a systematic review. Addiction (Abingdon, England) 107:501–517

    Article  Google Scholar 

  • Islam MM, Conigrave KM (2007) Assessing the role of syringe dispensing machines and mobile van outlets in reaching hard-to-reach and high-risk groups of injecting drug users (IDUs): a review. Harm Reduction J 4:14

    Article  Google Scholar 

  • Jones L, Pickering L, Sumnall H, McVeigh J, Bellis MA (2008) A review of the effectiveness and cost-effectiveness of needle and syringe programmes for injecting drug users. Res Rep. http://www.nice.org.uk/nicemedia/live/12130/43372/43372.pdf. Accessed 20 Mar 2013

  • Kerr D, Kelly A-M, Dietze P, Jolley D, Barger B (2009) Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular naloxone for the treatment of suspected heroin overdose. Addiction (Abingdon, England) 104:2067–2074

    Article  Google Scholar 

  • Kimber J, Palmateer N, Hutchinson S, Hickman M, Goldberg D, Rhodes T (2010) Harm reduction among injecting drug users – evidence of effectiveness. In: Rhodes T, Hedrich D (eds) Harm reduction: evidence, impacts and challenges. Publications Office of the European Union, Luxembourg, pp 115–164

    Google Scholar 

  • Knapp WP, Soares BGO, Farrel M, Lima MS (2007) Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders. Cochrane Database Syst Rev (Online) CD003023

    Google Scholar 

  • Lagu T, Anderson BJ, Stein M (2006) Overdoses among friends: drug users are willing to administer naloxone to others. J Subst Abus Treat 30:129–133

    Article  Google Scholar 

  • Latkin CA, Forman V, Knowlton A, Sherman S (2003) Norms, social networks, and HIV-related risk behaviors among urban disadvantaged drug users. Soc Sci Med 56:465–476

    Article  PubMed  Google Scholar 

  • Leonard L, DeRubeis E, Pelude L, Medd E, Birkett N, Seto J (2008) “I inject less as I have easier access to pipes”: injecting, and sharing of crack-smoking materials, decline as safer crack-smoking resources are distributed. Int J Drug Policy 19:255–264

    Article  PubMed  Google Scholar 

  • MacArthur GJ, Minozzi S, Martin N, Vickerman P, Deren S, Bruneau J, Degenhardt L, Hickman M (2012) Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis. BMJ (Clin Res Ed) 345:e5945

    Google Scholar 

  • Marshall BDL, Milloy M-J, Wood E, Montaner JSG, Kerr T (2011) Reduction in overdose mortality after the opening of North America’s first medically supervised safer injecting facility: a retrospective population-based study. Lancet 377:1429–1437

    Article  PubMed  Google Scholar 

  • Mattick RP, Kimber J, Breen C, Davoli M (2008) Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev (Online) CD002207

    Google Scholar 

  • Maxwell S, Bigg D, Stanczykiewicz K, Carlberg-Racich S (2006) Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths. J Addict Dis 25:89–96

    Article  PubMed  Google Scholar 

  • Meader N, Li R, Des Jarlais DC, Pilling S (2010) Psychosocial interventions for reducing injection and sexual risk behaviour for preventing HIV in drug users. Cochrane Database Syst Rev (Online) CD007192

    Google Scholar 

  • Meader N, Semaan S, Halton M, Bhatti H, Chan M, Llewellyn A, Des Jarlais DC (2013) An international systematic review and meta-analysis of multisession psychosocial interventions compared with educational or minimal interventions on the HIV sex risk behaviors of people who use drugs. AIDS Behav. doi:10.1007/s10461-012-0403-y

    PubMed  Google Scholar 

  • Needle RH, Coyle SL, Normand J, Lambert E, Cesari H (1998) HIV prevention with drug-using populations – current status and future prospects: introduction and overview. Pub Health Rep (Washington, DC: 1974) 113(Suppl):4–18

    PubMed Central  Google Scholar 

  • Needle RH, Burrows D, Friedman SR et al (2005) Effectiveness of community-based outreach in preventing HIV/AIDS among injecting drug users. Int J Drug Policy 16:45–57

    Article  Google Scholar 

  • NIDA (2000) An overview of the NIDA community-based outreach model. A manual to reduce the risk of HIV and other blood-borne infections in drug users. NIH Publication. http://archives.drugabuse.gov/CBOM/. Accessed 19 Mar 2013

  • NIDA (2006) Methadone research web guide. Part B: 20 questions and answers regarding methadone maintenance treatment research. Question 4. Online document. National Institute on Drug Abuse. http://international.drugabuse.gov/educational-opportunities/certificate-programs/methadone-research-web-guide/part-b/question-4-does-m. Accessed 7 Mar 2013

  • Palepu A, Tyndall MW, Joy R, Kerr T, Wood E, Press N, Hogg RS, Montaner JSG (2006) Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy. Drug Alcohol Depend 84:188–194

    Article  PubMed  Google Scholar 

  • Palmateer N, Kimber J, Hickman M, Hutchinson S, Rhodes T, Goldberg D (2010) Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews. Addiction (Abingdon, England) 105:844

    Article  Google Scholar 

  • Pizzey R, Hunt N (2008) Distributing foil from needle and syringe programmes (NSPs) to promote transitions from heroin injecting to chasing: an evaluation. Harm Reduction J 5:24

    Article  Google Scholar 

  • Pollini RA, McCall L, Mehta SH, Celentano DD, Vlahov D, Strathdee S (2006) Response to overdose among injection drug users. Am J Prev Med 31:261–264

    Article  PubMed  Google Scholar 

  • Rhodes T, Hartnoll RL (1991) Reaching the hard to reach: models of HIV outreach health education. In: Aggleton P, Hart G, Davies P (eds) AIDS: responses, interventions and care. The Falmer Press, London, pp 233–248

    Google Scholar 

  • Rhodes T, Hartnoll R (eds) (1996) AIDS, drugs and prevention: perspectives on individual and community action. Routledge, London/New York

    Google Scholar 

  • Rhodes R, Hedrich D (eds) (2010) Harm reduction: evidence, impacts and challenges, EMCDDA scientific monograph series no. 10. Publications Office of the European Union, Luxembourg. http://www.emcdda.europa.eu/publications/monographs/harm-reduction. Accessed 17 Mar 2013

  • Rhodes T, Stoneman A, Hope V, Hunt N, Martin A, Judd A (2006) Groin injecting in the context of crack cocaine and homelessness: from “risk boundary” to “acceptable risk”? Int J Drug Policy 17:164–170

    Article  Google Scholar 

  • Ritter A, Cameron J (2006) A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs. Drug Alcohol Rev 25:611–624

    Article  PubMed  Google Scholar 

  • Rush CR, Stoops WW (2012) Agonist replacement therapy for cocaine dependence: a translational review. Future Med Chem 4:245–265

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Semaan S, Des Jarlais DC, Sogolow E, Johnson WD, Hedges LV, Ramirez G, Flores SA, Norman L, Sweat MD, Needle R (2002) A meta-analysis of the effect of HIV prevention interventions on the sex behaviors of drug users in the United States. J Acquir Immune Defic Syndr 30(Suppl 1):S73–S93

    Article  PubMed  Google Scholar 

  • Semaan S, Neumann MS, Hutchins K, D’Anna LH, Kamb ML (2010) Brief counseling for reducing sexual risk and bacterial STIs among drug users – results from project RESPECT. Drug Alcohol Depend 106:7–15

    Article  PubMed  Google Scholar 

  • Shoptaw S, Reback CJ (2006) Associations between methamphetamine use and HIV among men who have sex with men: a model for guiding public policy. J Urban Health Bull N Y Acad Med 83:1151–1157

    Article  Google Scholar 

  • Small W, Kain S, Laliberte N, Schechter MT, O’Shaughnessy MV, Spittal PM (2005) Incarceration, addiction and harm reduction: inmates experience injecting drugs in prison. Subst Use Misuse 40:831–843

    Article  PubMed  Google Scholar 

  • Sorensen JL, Copeland AL (2000) Drug abuse treatment as an HIV prevention strategy: a review. Drug Alcohol Depend 59:17–31

    Article  CAS  PubMed  Google Scholar 

  • Stimson G, Des Jarlais DC, Ball A (1998) Drug injecting and HIV infection: global dimensions and local changes. University College of London Press, London

    Book  Google Scholar 

  • Stöver H, Nelles J (2003) Ten years of experience with needle and syringe exchange programmes in European prisons. Int J Drug Policy 14:437–444

    Article  Google Scholar 

  • Strang J, Manning V, Mayet S, Best D, Titherington E, Santana L, Offor E, Semmler C (2008) Overdose training and take-home naloxone for opiate users: prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses. Addiction (Abingdon, England) 103:1648–1657

    Article  Google Scholar 

  • Strang J, Groshkova T, Metrebian N (2012) New heroin-assisted treatment: recent evidence and current practices of supervised injectable heroin treatment in Europe and beyond, EMCDDA insights series no. 11. Publications Office of the European Union, Luxembourg

    Google Scholar 

  • The National Centre for HIV Epidemiology and Clinical Research (2009) Return on investment in needle and syringe programs in Australia: report. http://www.health.gov.au/internet/main/publishing.nsf/content/needle-return-1-sum. Accessed 7 Mar 2013

  • Tilson H, Aramrattana A, Bozzette S, Falco M, Hammett TM, Kozlov AP, Lai S, Mahal A, Schottenfeld RS, Solomon S, Celentano DD (2006) Preventing HIV infection among injecting drug users in high risk countries: an assessment of the evidence. Committee on the prevention of HIV infection among injecting drug users in high-risk countries, Institute of Medicine, The National Academies Press, Washington, DC. http://www.nap.edu/catalog.php?record_id=11731#toc. Accessed 17 Mar 2013

  • Turner KME, Hutchinson S, Vickerman P et al (2011) The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence. Addiction (Abingdon, England) 106:1978–1988

    Article  Google Scholar 

  • van den Berg C, Smit C, Van Brussel G, Coutinho R, Prins M (2007) Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users. Addiction (Abingdon, England) 102:1454–1462

    Article  Google Scholar 

  • Walley AY, Xuan Z, Hackman HH, Quinn E, Doe-Simkins M, Sorensen-Alawad A, Ruiz S, Ozonoff A (2013) Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ 346:f174–f174

    Article  PubMed  Google Scholar 

  • WHO (2004a) Effectiveness of sterile needle and syringe programming in reducing HIV/AIDS among IDUs, Evidence for action technical paper and policy brief. WHO, Geneva. http://www.who.int/hiv/pub/idu/e4a-needle/en/index.html. Accessed 5 Mar 2013

  • WHO (2004b) Effectiveness of community-based outreach in preventing HIV/AIDS among injecting drug users, Evidence for action paper. WHO, Geneva. http://www.who.int/hiv/pub/idu/idu/en/. Accessed 3 Mar 2013

  • WHO (2009) Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. WHO, Geneva. http://www.who.int/substance_abuse/publications/9789241547543/en/index.html. Accessed 3 Mar 2013

  • WHO (2010) Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: recommendations for a public health approach – 2010 version. WHO, Geneva. http://www.who.int/hiv/pub/mtct/antiretroviral2010/en/index.html. Accessed 3 Mar 2013

  • WHO (2012) Guidance on prevention of viral hepatitis B and C among people who inject drugs. WHO, Geneva. http://www.who.int/hiv/pub/guidelines/hepatitis/en/index.html. Accessed 3 Mar 2013

  • WHO, UNAIDS, UNODC (2007) Effectiveness of interventions to address HIV in prisons, Evidence for action technical paper. WHO, Geneva. http://whqlibdoc.who.int/publications/2007/9789241596190_eng.pdf. Accessed 3 Mar 2013

  • WHO, UNAIDS, UNODC (2013) Technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users, 2012 revision. World Health Organization, Geneva. http://www.who.int/hiv/pub/idu/targets_universal_access/en/index.html. Accessed 3 Mar 2013

  • Williamson A, Darke S, Ross J, Teesson M (2006) The association between cocaine use and short-term outcomes for the treatment of heroin dependence: findings from the Australian Treatment Outcome Study (ATOS). Drug Alcohol Rev 25:141–148

    Article  PubMed  Google Scholar 

  • Wood E, Kerr T, Spittal PM, Small W, Tyndall MW, O’Shaughnessy MV, Schechter MT (2003) An external evaluation of a peer-run “unsanctioned” syringe exchange program. J Urban Health Bull N Y Acad Med 80:455–464

    Article  Google Scholar 

  • Wright NMJ, Tompkins CNE (2006) A review of the evidence for the effectiveness of primary prevention interventions for hepatitis C among injecting drug users. Harm Reduction J 3:27

    Article  Google Scholar 

  • Zule WA, Cross HE, Stover J, Pretorius C (2013) Are major reductions in new HIV infections possible with people who inject drugs? The case for low dead-space syringes in highly affected countries. The Int J Drug Policy 24:1–7

    Article  PubMed  Google Scholar 

Further Reading

  • Centers for Disease Control and Prevention (CDC) (2012) Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the U.S. Department of Health and Human Services. MMWR 61(RR05):1–43. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6105a1.htm. Accessed 5 Mar 2013

  • ECDC, EMCDDA (2011) Prevention and control of infectious diseases among people who inject drugs, ECDC and EMCDDA joint guidance. European Centre for Disease Prevention and Control, Stockholm

    Google Scholar 

  • Rhodes R, Hedrich D (eds) (2010) Harm reduction: evidence, impacts and challenges, EMCDDA scientific monograph series no. 10. Publications Office of the European Union, Luxembourg. http://www.emcdda.europa.eu/publications/monographs/harm-reduction. Accessed 17 Mar 2013

  • Tilson H, Aramrattana A, Bozzette S, Falco M, Hammett TM, Kozlov AP, Lai S, Mahal A, Schottenfeld R, Solomon RS, Celentano DD (2006) Preventing HIV infection among injecting drug users in high risk countries: an assessment of the evidence. Committee on the prevention of HIV infection among injecting drug users in high-risk countries, Institute of Medicine, The National Academies Press, Washington, DC. http://www.nap.edu/catalog.php?record_id=11731#toc Accessed 17 Mar 2013

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dagmar Hedrich .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Italia

About this entry

Cite this entry

Hedrich, D., Hartnoll, R. (2015). Harm Reduction Interventions. In: el-Guebaly, N., Carrà, G., Galanter, M. (eds) Textbook of Addiction Treatment: International Perspectives. Springer, Milano. https://doi.org/10.1007/978-88-470-5322-9_133

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-5322-9_133

  • Published:

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-5321-2

  • Online ISBN: 978-88-470-5322-9

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics